Skip NavigationSkip to Content

The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Mamu-B*08(+) Rhesus Macaques

  1. Author:
    Martins, Mauricio A.
    Gonzalez-Nieto, Lucas
    Shin, Young C.
    Domingues, Aline
    Gutman, Martin J.
    Maxwell, Helen S.
    Magnani, Diogo M.
    Ricciardi, Michael J.
    Pedreno-Lopez, Nuria
    Bailey, Varian K.
    Altman, John D.
    Parks, Christopher L.
    Allison, David B.
    Ejima, Keisuke
    Rakasz, Eva G.
    Capuano, Saverio
    Desrosiers, Ronald C.
    Lifson, Jeffrey
    Watkins, David
  2. Author Address

    Univ Miami, Dept Pathol, Miami, FL 33136 USA.Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.AIDS Vaccine Design & Dev Lab, Int AIDS Vaccine Initiat, Brooklyn, NY USA.Indiana Univ Bloomington, Sch Publ Hlth, Bloomington, IN USA.Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Procitarn, Frederick, MD USA.Lonza Houston, Res & Dev, Houston, TX USA.Univ Massachusetts, Sch Med, MassBIol, Boston, MA 02125 USA.
    1. Year: 2019
    2. Date: Feb 19
    3. Epub Date: 2018 12 12
  1. Journal: Journal of virology
  2. AMER SOC MICROBIOLOGY,
    1. 93
  3. Type of Article: Article
  4. Article Number: e01626-18
  5. ISSN: 0022-538X
  1. Abstract:

    Approximately 50% of rhesus macaques (RMs) expressing the major histocompatibility complex class I (MHC-I) allele Mamu-B* 08 spontaneously control chronic-phase viremia after infection with the pathogenic simian immunodeficiency virus mac239 (SIVmac239) clone. CD8(+) T-cell responses in these animals are focused on immunodominant Mamu-B* 08-restricted SIV epitopes in Vif and Nef, and prophylactic vaccination with these epitopes increases the incidence of elite control in SIVmac239-infected Mamu-B* 08-positive (Mamu-B* 08(+)) RMs. Here we evaluated if robust vaccine-elicited CD8(+) T-cell responses against Vif and Nef can prevent systemic infection in Mamu-B* 08(+) RMs following mucosal SIV challenges. Ten Mamu-B* 08(+) RMs were vaccinated with a heterologous prime/boost/boost regimen encoding Vif and Nef, while six sham-vaccinated MHC-I-matched RMs served as the controls for this experiment. Vaccine-induced CD8(+) T cells against Mamu-B* 08-restricted SIV epitopes reached high frequencies in blood but were present at lower levels in lymph node and gut biopsy specimens. Following repeated intrarectal challenges with SIVmac239, all control RMs became infected by the sixth SIV exposure. By comparison, four vaccinees were still uninfected after six challenges, and three of them remained aviremic after 3 or 4 additional challenges. The rate of SIV acquisition in the vaccinees was numerically lower (albeit not statistically significantly) than that in the controls. However, peak viremia was significantly reduced in infected vaccinees compared to control animals. We found no T-cell markers that distinguished vaccinees that acquired SIV infection from those that did not. Additional studies will be needed to validate these findings and determine if cellular immunity can be harnessed to prevent the establishment of productive immunodeficiency virus infection.

    See More

External Sources

  1. DOI: 10.1128/JVI.01626-18
  2. PMID: 30541854
  3. WOS: 000459022000011

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel